| Literature DB >> 27187333 |
Jiri Mlcek1, Tunde Jurikova2, Sona Skrovankova3, Jiri Sochor4.
Abstract
Quercetin is the great representative of polyphenols, flavonoids subgroup, flavonols. Its main natural sources in foods are vegetables such as onions, the most studied quercetin containing foods, and broccoli; fruits (apples, berry crops, and grapes); some herbs; tea; and wine. Quercetin is known for its antioxidant activity in radical scavenging and anti-allergic properties characterized by stimulation of immune system, antiviral activity, inhibition of histamine release, decrease in pro-inflammatory cytokines, leukotrienes creation, and suppresses interleukin IL-4 production. It can improve the Th1/Th2 balance, and restrain antigen-specific IgE antibody formation. It is also effective in the inhibition of enzymes such as lipoxygenase, eosinophil and peroxidase and the suppression of inflammatory mediators. All mentioned mechanisms of action contribute to the anti-inflammatory and immunomodulating properties of quercetin that can be effectively utilized in treatment of late-phase, and late-late-phase bronchial asthma responses, allergic rhinitis and restricted peanut-induced anaphylactic reactions. Plant extract of quercetin is the main ingredient of many potential anti-allergic drugs, supplements and enriched products, which is more competent in inhibiting of IL-8 than cromolyn (anti-allergic drug disodium cromoglycate) and suppresses IL-6 and cytosolic calcium level increase.Entities:
Keywords: anti-allergic effect; anti-inflammatory properties; flavonoids; immune response; quercetin
Mesh:
Substances:
Year: 2016 PMID: 27187333 PMCID: PMC6273625 DOI: 10.3390/molecules21050623
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structure of quercetin.
Summarization of quercetin and its anti-allergic effect—in vitro studies.
| Effect | Studied Models | Mechanism of Action | References |
|---|---|---|---|
| rats | Stabilization of mast cell membrane | Johri
| |
| Inhibition of leucotriens release, prostaglandin D2, Ca2+ influx | Kimata
| ||
| Human cultured mast cells | Release of IL-6, IL-8, TNF-2, inhibition of tryptase release, activation of NF-κB | Kempuraj
| |
| Decrease of tryptase, MCP-1, IL-6, histidine decarboxylase (HDC) | Shaik
| ||
| Antigen sensitized human mast cells | Normal path of Ca2+ entry to cells, inhibition of leucotrienes, PGD-2 | Fewtrell and Gomperts [ | |
| Rats mast cells | Release of immunologically induced cells, inhibition of anaphylactic histamine | Haagag
| |
| ovalbumin-challenged mice | release from mucosal cells, inhibited eosinophil peroxidase activity and protein content in bronchoalveolar lavage fluid (BALF) | Kaiser
| |
| OVA-induced asthma model rats | Reduction of eosinophil peroxidase activity, level of IL-4, Th2 cytokine production | Park
| |
| Murine model of asthma | Decrease in eosinophil counts in bronchoalveolar lavage fluid, inhibition of NF-kappa B | Roger
| |
| Male A/J mice | Isoproterenol induced relaxation | Towsend and Emala [ | |
| Smoth muscle murine model of asthma | Reduction of production of inflammatory cytokines | Oliveira
| |
| (OVA)-sensitized conscious guinea pigs | Inhibitory activity of quercetin inhalation on sRaw (specific airway resistance) | Jung
| |
| Isolated tracheal tissue | Concentration-dependent inhibition of contractions induced by both carbachol and electrical field stimulation | Capasso
| |
| Wister rats | Plasma histamine levels in the quercetin-treated rats were lower significantly, regulate mucosal immunity during hypersensitivity reaction | Shiseboar
|